CC
VRTX icon

Cipher Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Cipher Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$389K Sell
930
-513
-36% -$217K 0.18% 208
2023
Q4 		$587K Buy
+1,443
New +$533K 0.19% 176
2023
Q3 		– Sell
-870
Closed -$306K – 618
2023
Q2 		$306K Buy
+870
New +$293K 0.05% 401

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cipher Capital's VRTX Position: Q1 2024 in Review

Cipher Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 36% in Q1 2024, selling an estimated $217K and leaving 930 shares worth $389K. The position accounts for 0.18% of the portfolio, ranked #208.

Cipher Capital first reported a position in VRTX in Q2 2023 and has held it in 3 quarters since. The position peaked at $587K in Q4 2023. 1,494 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

  • Cipher Capital held 930 shares of Vertex Pharmaceuticals worth $389K as of Q1 2024.
  • Cipher Capital sold 513 Vertex Pharmaceuticals shares in Q1 2024, an estimated $217K.
  • Vertex Pharmaceuticals made up 0.18% of Cipher Capital's portfolio in Q1 2024, its #208 holding.
  • Cipher Capital first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 3 quarters since.
  • Cipher Capital's Vertex Pharmaceuticals position peaked at $587K in Q4 2023.
  • 1,494 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.